eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

SCImago Journal & Country Rank
 
2/2006
vol. 5
 
Share:
Share:
more
 
 
abstract:

The influence of transdermal hormone therapy on thromboembolic risk of women at menopausal period

Tomasz Pertyński
,
Grzegorz Stachowiak
,
Tomasz Stetkiewicz
,
Urszula Faflik

Prz Menopauz 2006; 2: 92–95
Online publish date: 2006/05/12
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The present article is a short review of up-to-date reports on the influence of hormone therapy (HT) on the hemostatic elements responsible for thromboembolic complications, being one of the most threatening side effect of HT administration in women at menopausal period. Transdermal HT, in a far less degree than the oral type of this therapy does it, modifies (=increases) the vascular risk of thromboembolic events. Hence it should be a therapy of the first choice for women at increased risk of thromboembolic complications in circulatory system.
keywords:

thromboembolic risk, transdermal hormone therapy, coagulation, fibrinolysis, menopause

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.